# CIPLA share price, delivery % and history — Cipla Limited

> Delivery percentage for Cipla Limited (CIPLA) against its own history, with 7,850 sessions of split-adjusted NSE data from 1995 — plus moving averages, RSI and the 52-week range.

Canonical: https://patternsradar.com/s/CIPLA

NSE · equity · [Healthcare](https://patternsradar.com/stocks/sector/healthcare.md) · [Pharmaceuticals & Biotechnology](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md)

## Latest session

- Close: 1,346 INR (-2.41% on the day), 2026-09-30
- Delivery: 52.76% of volume taken to demat (20-day average 56.33%)
- Volume: 10.64L shares, turnover ₹143.2Cr
- Relative volume: 1.08× of its own 20-day average

## Technicals

- RSI(14): 35.23
- ATR(14): 26.31
- SMA 50: 1,416.62, SMA 200: 1,381.54
- 52-week range: 1,165.7 – 1,673 (-19.55% from the high)

## Performance

- 1 week -2.68%, 1 month -4.48%, 3 months -7.55%
- 6 months 8.35%, 1 year -11.86%

## Delivery percentage

- Latest: 52.76% (2026-09-30)
- 20-day average: 56.33%
- 1-year average: 55.8%
- Percentile against its own history: 60th
- Range: 6.93% – 81.08% across 1,728 sessions with a reading

Over the last 20 sessions CIPLA settled 56.3% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 55.8%. The latest session ranks higher than 60% of the 1,728 sessions on record for it.

[What delivery percentage measures](https://patternsradar.com/learn/delivery-percentage.md). [Scan the whole market on delivery](https://patternsradar.com/scans/delivery.md).

## Fundamentals

- Market cap: 1,08,737.7 crore
- P/E (TTM): 32.4 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 41.54 INR, split-adjusted to match the price series
- Revenue growth: 2.33% YoY, 8.84% QoQ
- Profit growth: -39.18% YoY, 44.8% QoQ

Compound annual growth, trailing-twelve-month against the same measure N years earlier:

| Window | Revenue | Profit |
| --- | --- | --- |
| 2y | 4.1% | -11.98% |
| 3y | 6.11% | 2.4% |
| 5y | 6.87% | 5.79% |
| 6y | 8.37% | 12.92% |
| 7y | 8.11% | 12.25% |

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 7,051 | 5,452.6 | 1,789.1 | 1,305 | 16.13 | 18.51% |
| 2024-12-31 | 7,073 | 5,378.5 | 1,916.1 | 1,574.6 | 19.45 | 22.26% |
| 2025-03-31 | 6,729.7 | 5,514.9 | 1,504.3 | 1,214.1 | 15.13 | 18.04% |
| 2025-06-30 | 6,957.5 | 5,446.1 | 1,769.9 | 1,291.6 | 16.07 | 18.56% |
| 2025-09-30 | 7,589.4 | 6,004.9 | 1,853.5 | 1,353.4 | 16.73 | 17.83% |
| 2025-12-31 | 7,074.5 | 6,111.8 | 893.1 | 674.3 | 8.37 | 9.53% |
| 2026-03-31 | 6,541.2 | 5,982.3 | 707.1 | 542.5 | 6.87 | 8.29% |
| 2026-06-30 | 7,119.3 | 6,248.3 | 1,081.9 | 785.6 | 9.77 | 11.03% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 29.21%
- Public: 70.79%
- FII: 20.21%, DII: 34.63%
- Promoter shares pledged: 0%

## Recent filings

- 2026-07-23: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_177481_23072026183436_iXBRL_WEB.html
- 2026-07-21: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1698044_21072026022401_WEB.xml
- 2026-06-05: dividend
- 2026-05-13: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_157348_13052026205230_iXBRL_WEB.html
- 2026-04-21: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1712107_11082026072853_WEB.xml
- 2026-01-23: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_137122_23012026181814_iXBRL_WEB.html
- 2026-01-21: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1607774_21012026090606_WEB.xml
- 2025-10-30: results for 2025-09-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_123833_30102025220011_iXBRL_WEB.html

Dated by the day the company broadcast the filing. 118 events are indexed for this instrument.

## About the instrument

- Listed: 1995-01-02 — latest session 2026-09-30 (7,850 sessions)
- ISIN: INE059A01026
- Series: EQ
- Liquidity rank: #223 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

## More in Pharmaceuticals & Biotechnology

- [DIVISLAB](https://patternsradar.com/s/DIVISLAB.md) — Divi's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [LAURUSLABS](https://patternsradar.com/s/LAURUSLABS.md) — Laurus Labs Limited (Pharmaceuticals & Biotechnology)
- [WOCKPHARMA](https://patternsradar.com/s/WOCKPHARMA.md) — Wockhardt Limited (Pharmaceuticals & Biotechnology)
- [SUNPHARMA](https://patternsradar.com/s/SUNPHARMA.md) — Sun Pharmaceutical Industries Limited (Pharmaceuticals & Biotechnology)
- [MOREPENLAB](https://patternsradar.com/s/MOREPENLAB.md) — Morepen Laboratories Limited (Pharmaceuticals & Biotechnology)
- [DRREDDY](https://patternsradar.com/s/DRREDDY.md) — Dr. Reddy's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [SYMBIOTEC](https://patternsradar.com/s/SYMBIOTEC.md) — SYMBIOTEC (Pharmaceuticals & Biotechnology)
- [GLAND](https://patternsradar.com/s/GLAND.md) — Gland Pharma Limited (Pharmaceuticals & Biotechnology)
- [ZYDUSLIFE](https://patternsradar.com/s/ZYDUSLIFE.md) — Zydus Lifesciences Limited (Pharmaceuticals & Biotechnology)
- [TORNTPHARM](https://patternsradar.com/s/TORNTPHARM.md) — Torrent Pharmaceuticals Limited (Pharmaceuticals & Biotechnology)
- [LUPIN](https://patternsradar.com/s/LUPIN.md) — Lupin Limited (Pharmaceuticals & Biotechnology)
- [AHCL](https://patternsradar.com/s/AHCL.md) — Anlon Healthcare Limited (Pharmaceuticals & Biotechnology)

[All Pharmaceuticals & Biotechnology stocks on the NSE](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md) · [All Healthcare stocks on the NSE](https://patternsradar.com/stocks/sector/healthcare.md)

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/CIPLA.

---

Price and delivery data from the [eod2](https://github.com/BennyThadikaran/eod2) dataset: National Stock Exchange of India end-of-day files, split- and bonus-adjusted, updated after each close. Not affiliated with or endorsed by NSE. PatternsRadar is a research tool. Nothing here is investment advice or a recommendation to buy or sell anything.